DeepMed Research

VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Clinical Neurobiology of Serotonin and Addiction

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Placebo
Drug: Escitalopram

First Posted Date: 2008-08-12

Last Posted Date: 2019-03-08

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 160

Registration Number: NCT00732901

Locations: 🇺🇸
University of Texas Health Science Center-Houston; Substance Abuse Research Clinic, Houston, Texas, United States

Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome

Not Applicable

Terminated

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Placebo
Drug: Flutamide

First Posted Date: 2008-08-07

Last Posted Date: 2014-09-08

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 8

Registration Number: NCT00729560

Locations: 🇺🇸
Virginia Commonwealth University General Clinical Research Center, Richmond, Virginia, United States

5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome

Phase 2

Completed

Conditions: Myelodysplastic Syndrome

Interventions: Drug: 5-azacytidine

First Posted Date: 2008-07-24

Last Posted Date: 2016-03-02

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 16

Registration Number: NCT00721214

Locations: 🇺🇸
Massey Cancer Center / Virginia Commonwealth University, Richmond, Virginia, United States

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

Phase 2

Completed

Conditions: Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Acute Myeloid Leukemia
Leukemia
Multiple Myeloma
Myelodysplastic Syndrome
Non-Hodgkin's Lymphoma

Interventions: Biological: Thymoglobulin
Radiation: Total-Body Irradiation
Procedure: Allogeneic PBSCT or BMT
Drug: Tacrolimus
Drug: Mycophenolate Mofetil

First Posted Date: 2008-07-03

Last Posted Date: 2018-11-09

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 42

Registration Number: NCT00709592

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Pharmacogenetics of Metformin Action in PCOS

Not Applicable

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Metformin 500 mg tablet

First Posted Date: 2008-06-23

Last Posted Date: 2017-06-14

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 55

Registration Number: NCT00703508

Locations: 🇺🇸
University Of Virginia General Clinical Research Center, Charlottesville, Virginia, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Pilot Study:Role of Dietary Fiber in PCOS Anovulation

Phase 4

Terminated

Conditions: PCOS

Interventions: Drug: Fiber-Stat

First Posted Date: 2008-06-23

Last Posted Date: 2017-10-09

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 2

Registration Number: NCT00703092

Locations: 🇺🇸
VCU General Clinical Research Center, Richmond, Virginia, United States

Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC

Phase 1

Terminated

Conditions: Non-small Cell Lung Cancer

Interventions: Radiation: Fractionated radiation therapy followed by chemotherapy

First Posted Date: 2008-06-06

Last Posted Date: 2016-05-02

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 28

Registration Number: NCT00692380

Locations: 🇺🇸
Massey Cancer Center, Richmond, Virginia, United States

Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate

Phase 1

Withdrawn

Conditions: Prostate Cancer

Interventions: Radiation: Radiation Therapy followed by prostatectomy

First Posted Date: 2008-06-06

Last Posted Date: 2013-04-24

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT00691977

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

A Prospective Study of Natural History of Pancreatitis

Completed

Conditions: Chronic Pancreatitis

First Posted Date: 2008-05-28

Last Posted Date: 2013-05-21

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 300

Registration Number: NCT00685087

Locations: 🇺🇸
Virginia Commonwealth University Medical center, Richmond, Virginia, United States

Insulin and Polycystic Ovary Syndrome

Not Applicable

Completed

Conditions: PCOS

Interventions: Drug: diazoxide

First Posted Date: 2008-05-23

Last Posted Date: 2017-06-14

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 21

Registration Number: NCT00683774

Locations: 🇺🇸
General Clinical Research Center, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy